ArticleFood science & nutrition2026

Aspirin Use Does Not Significantly Reduce the Risk of Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Linlin Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.